Comments
#Below 1000, again: India’s new Covid-19 cases dipped below 1000, again. According to Health Ministry data, 795 new cases were recorded in the last 24 hours, and 58 deaths. India has administered over 184.87 crore total doses of the Covid-19 vaccine so far.
Related Stories
Covid-19 vaccination: India has administered more than 184.87 crore total doses so far
#Not twice bitten: Having cancelled his visit to India twice last year, due to the pandemic, the British Prime Minister Boris Johnson is scheduled to visit around April 22nd.
Related Stories
UK PM Boris Johnson expected to visit India this month
The visit, which is expected around April 22, is long overdue after Johnson was forced to cancel planned visits to India twice last year due to the Covid-19 pandemic#Familiar concern, now raised on a vaccine: A concern often raised on medicines is now being brought up in the context of vaccines. How does a medical product that runs into regulatory issues internationally, continue to be safe for the domestic market? The query comes up this time against the backdrop of weekend developments, where the World Health Organization (WHO) said it suspended supply of Bharat Biotech’s Covaxin through United Nation agencies.
Related Stories
WHO’s move on Covaxin brings back a question often asked of medicines
Bharat Biotech announced it was slowing down to focus on pending facility maintenance, process and facility optimisation activities#Deal-street’s back: Elaine Tan, Senior Analyst at Refinitiv says that global deal-making fell to its lowest opening period since 2020, the start of the Covid-19 pandemic, but M&A activity involving India witnessed a strong start as the first quarter period reached a four-year high.
Related Stories
India M&A activity hits four-year high at $30.3 billion in Jan-March: Refinitiv
However, equity capital markets activity was down 64.3 per cent to $ 3.1 billion#Call for urgent action: Unfortunately, the past year has witnessed a worsening of the global TB pandemic. For the first time in a decade, more people died of TB last year than in the year prior. And this is partly due to the impact of Covid-19.
Related Stories
No one is moving fast enough to end TB
India has lagged in implementing new TB treatments shown to be safe and effective
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.